Able 0 4 0 4 O
to 5 7 5 7 O
swallow 8 15 8 15 O
and 16 19 16 19 O
retain 20 26 20 26 O
orally 27 33 27 33 O
administered 34 46 34 46 O
medication 47 57 47 57 O
and 58 61 58 61 O
does 62 66 62 66 O
not 67 70 67 70 O
have 71 75 71 75 O
any 76 79 76 79 O
clinically 80 90 80 90 O
significant 91 102 91 102 O
gastrointestinal 103 119 103 119 B-chronic_disease
abnormalities 120 133 120 133 I-chronic_disease
that 134 138 134 138 O
may 139 142 139 142 O
alter 143 148 143 148 O
absorption 149 159 149 159 O
such 160 164 160 164 O
as 165 167 165 167 O
malabsorption 168 181 168 181 B-chronic_disease
syndrome 182 190 182 190 I-chronic_disease
or 191 193 191 193 O
major 194 199 194 199 O
resection 200 209 200 209 O
of 210 212 210 212 O
the 213 216 213 216 O
stomach 217 224 217 224 O
or 225 227 225 227 O
bowels 228 234 228 234 O

Absolute 0 8 235 243 B-clinical_variable
neutrophil 9 19 244 254 I-clinical_variable
count 20 25 255 260 I-clinical_variable
greater 26 33 261 268 O
than 34 38 269 273 O
or 39 41 274 276 O
equal 42 47 277 282 O
to 48 50 283 285 O
1.5 51 54 286 289 B-lower_bound
x 55 56 290 291 I-lower_bound
109 57 60 292 295 I-lower_bound
cells 61 66 296 301 I-lower_bound
/ 66 67 301 302 I-lower_bound
L 67 68 302 303 I-lower_bound
, 68 69 303 304 O
hemoglobin 70 80 305 315 B-clinical_variable
greater 81 88 316 323 O
than 89 93 324 328 O
or 94 96 329 331 O
equal 97 102 332 337 O
to 103 105 338 340 O
8.0 106 109 341 344 B-lower_bound
g 110 111 345 346 I-lower_bound
/ 111 112 346 347 I-lower_bound
dL 112 114 347 349 I-lower_bound
, 114 115 349 350 O
platelets 116 125 351 360 B-clinical_variable
greater 126 133 361 368 O
than 134 138 369 373 O
or 139 141 374 376 O
equal 142 147 377 382 O
to 148 150 383 385 O
75 151 153 386 388 B-lower_bound
x 154 155 389 390 I-lower_bound
109 156 159 391 394 I-lower_bound
/ 159 160 394 395 I-lower_bound
L 160 161 395 396 I-lower_bound
, 161 162 396 397 O
creatinine 163 173 398 408 B-clinical_variable
less 174 178 409 413 O
than 179 183 414 418 O
or 184 186 419 421 O
equal 187 192 422 427 O
to 193 195 428 430 O
1.5 196 199 431 434 B-upper_bound
X 200 201 435 436 I-upper_bound
upper 202 207 437 442 B-clinical_variable
limit 208 213 443 448 I-clinical_variable
of 214 216 449 451 I-clinical_variable
normal 217 223 452 458 I-clinical_variable
( 224 225 459 460 I-clinical_variable
ULN 225 228 460 463 I-clinical_variable
) 228 229 463 464 I-clinical_variable
with 230 234 465 469 O
calculated 235 245 470 480 O
creatinine 246 256 481 491 B-clinical_variable
clearance 257 266 492 501 I-clinical_variable
greater 267 274 502 509 O
than 275 279 510 514 O
30 280 282 515 517 B-lower_bound
ml 283 285 518 520 I-lower_bound
/ 285 286 520 521 I-lower_bound
min 286 289 521 524 I-lower_bound
, 289 290 524 525 O
total 291 296 526 531 O
bilirubin 297 306 532 541 B-clinical_variable
less 307 311 542 546 O
than 312 316 547 551 O
or 317 319 552 554 O
equal 320 325 555 560 O
to 326 328 561 563 O
1.5 329 332 564 567 O
X 333 334 568 569 O
ULN 335 338 570 573 O
, 338 339 573 574 O
AST(SGOT 340 348 575 583 B-clinical_variable
) 348 349 583 584 I-clinical_variable
and/or 350 356 585 591 O
ALT(SGPT 357 365 592 600 B-clinical_variable
) 365 366 600 601 I-clinical_variable
less 367 371 602 606 O
than 372 376 607 611 O
or 377 379 612 614 O
equal 380 385 615 620 O
to 386 388 621 623 O
3 389 390 624 625 B-upper_bound
XULN 391 395 626 630 I-upper_bound

Diagnosed 0 9 631 640 O
or 10 12 641 643 O
treated 13 20 644 651 O
for 21 24 652 655 O
another 25 32 656 663 O
malignancy 33 43 664 674 B-cancer
within 44 50 675 681 O
2 51 52 682 683 B-upper_bound
years 53 58 684 689 I-upper_bound
before 59 65 690 696 O
study 66 71 697 702 O
enrollment 72 82 703 713 O
or 83 85 714 716 O
previously 86 96 717 727 O
diagnosed 97 106 728 737 O
with 107 111 738 742 O
another 112 119 743 750 O
malignancy 120 130 751 761 O
and 131 134 762 765 O
have 135 139 766 770 O
any 140 143 771 774 O
evidence 144 152 775 783 O
of 153 155 784 786 O
residual 156 164 787 795 O
disease 165 172 796 803 O

Evidence 0 8 804 812 O
of 9 11 813 815 O
current 12 19 816 823 O
uncontrolled 20 32 824 836 O
cardiovascular 33 47 837 851 B-chronic_disease
conditions 48 58 852 862 I-chronic_disease
, 58 59 862 863 O
including 60 69 864 873 O
uncontrolled 70 82 874 886 B-chronic_disease
hypertension 83 95 887 899 I-chronic_disease
, 95 96 899 900 O
uncontrolled 97 109 901 913 O
cardiac 110 117 914 921 B-chronic_disease
arrhythmias 118 129 922 933 I-chronic_disease
, 129 130 933 934 O
symptomatic 131 142 935 946 O
congestive 143 153 947 957 B-chronic_disease
heart 154 159 958 963 I-chronic_disease
failure 160 167 964 971 I-chronic_disease
, 167 168 971 972 O
unstable 169 177 973 981 B-chronic_disease
angina 178 184 982 988 I-chronic_disease
, 184 185 988 989 O
or 186 188 990 992 O
myocardial 189 199 993 1003 B-chronic_disease
infarction 200 210 1004 1014 I-chronic_disease
within 211 217 1015 1021 O
the 218 221 1022 1025 O
past 222 226 1026 1030 B-upper_bound
6 227 228 1031 1032 I-upper_bound
months 229 235 1033 1039 I-upper_bound

Failure 0 7 1040 1047 O
from 8 12 1048 1052 O
anti 13 17 1053 1057 B-treatment
- 17 18 1057 1058 I-treatment
EGFR 18 22 1058 1062 I-treatment
therapy 23 30 1063 1070 I-treatment
will 31 35 1071 1075 O
be 36 38 1076 1078 O
defined 39 46 1079 1086 O
as 47 49 1087 1089 O
progressive 50 61 1090 1101 O
disease 62 69 1102 1109 O
by 70 72 1110 1112 O
RECIST 73 79 1113 1119 O
( 80 81 1120 1121 O
Version 81 88 1121 1128 O
1.1 89 92 1129 1132 O
) 92 93 1132 1133 O
after 94 99 1134 1139 O
at 100 102 1140 1142 O
least 103 108 1143 1148 O
two 109 112 1149 1152 B-lower_bound
months 113 119 1153 1159 I-lower_bound
of 120 122 1160 1162 O
therapy 123 130 1163 1170 O

Female 0 6 1171 1177 B-gender
patients 7 15 1178 1186 I-gender
who 16 19 1187 1190 O
are 20 23 1191 1194 O
lactating 24 33 1195 1204 O
or 34 36 1205 1207 O
have 37 41 1208 1212 O
a 42 43 1213 1214 O
positive 44 52 1215 1223 B-pregnancy
serum 53 58 1224 1229 I-pregnancy
pregnancy 59 68 1230 1239 I-pregnancy
test 69 73 1240 1244 O
suggestive 74 84 1245 1255 O
of 85 87 1256 1258 O
pregnancy 88 97 1259 1268 O
and 98 101 1269 1272 O
not 102 105 1273 1276 O
as 106 108 1277 1279 O
a 109 110 1280 1281 O
tumor 111 116 1282 1287 B-cancer
marker 117 123 1288 1294 O
during 124 130 1295 1301 O
the 131 134 1302 1305 O
screening 135 144 1306 1315 O
period 145 151 1316 1322 O

Female 0 6 1323 1329 B-gender
patients 7 15 1330 1338 I-gender
who 16 19 1339 1342 O
: 19 20 1342 1343 O
Are 21 24 1344 1347 O
postmenopausal 25 39 1348 1362 O
for 40 43 1363 1366 O
at 44 46 1367 1369 O
least 47 52 1370 1375 O
1 53 54 1376 1377 B-lower_bound
year 55 59 1378 1382 I-lower_bound
before 60 66 1383 1389 O
the 67 70 1390 1393 O
screening 71 80 1394 1403 O
visit 81 86 1404 1409 O

Have 0 4 1410 1414 O
a 5 6 1415 1416 O
known 7 12 1417 1422 O
immediate 13 22 1423 1432 O
or 23 25 1433 1435 O
delayed 26 33 1436 1443 O
hypersensitivity 34 50 1444 1460 O
reaction 51 59 1461 1469 O
or 60 62 1470 1472 O
idiosyncrasy 63 75 1473 1485 O
to 76 78 1486 1488 O
drugs 79 84 1489 1494 B-allergy_name
chemically 85 95 1495 1505 I-allergy_name
related 96 103 1506 1513 I-allergy_name
to 104 106 1514 1516 I-allergy_name
study 107 112 1517 1522 I-allergy_name
drug 113 117 1523 1527 I-allergy_name
, 117 118 1527 1528 O
or 119 121 1529 1531 O
excipients 122 132 1532 1542 B-allergy_name
or 133 135 1543 1545 O
to 136 138 1546 1548 O
dimethyl 139 147 1549 1557 B-allergy_name
sulfoxide 148 157 1558 1567 I-allergy_name
( 158 159 1568 1569 I-allergy_name
DMSO 159 163 1569 1573 I-allergy_name
) 163 164 1573 1574 I-allergy_name

Infection 0 9 1575 1584 O
requiring 10 19 1585 1594 O
systemic 20 28 1595 1603 B-treatment
antibiotic 29 39 1604 1614 I-treatment
therapy 40 47 1615 1622 I-treatment
or 48 50 1623 1625 O
other 51 56 1626 1631 O
serious 57 64 1632 1639 O
infection 65 74 1640 1649 B-chronic_disease
within 75 81 1650 1656 O
14 82 84 1657 1659 B-upper_bound
days 85 89 1660 1664 I-upper_bound
before 90 96 1665 1671 O
study 97 102 1672 1677 O
enrollment 103 113 1678 1688 O

Life 0 4 1689 1693 B-clinical_variable
expectancy 5 15 1694 1704 I-clinical_variable
of 16 18 1705 1707 O
at 19 21 1708 1710 O
least 22 27 1711 1716 O
3 28 29 1717 1718 B-lower_bound
months 30 36 1719 1725 I-lower_bound
in 37 39 1726 1728 O
the 40 43 1729 1732 O
opinion 44 51 1733 1740 O
of 52 54 1741 1743 O
investigator 55 67 1744 1756 O

Major 0 5 1757 1762 B-treatment
surgery 6 13 1763 1770 I-treatment
within 14 20 1771 1777 O
14 21 23 1778 1780 B-upper_bound
days 24 28 1781 1785 I-upper_bound
before 29 35 1786 1792 O
enrollment 36 46 1793 1803 O

Male 0 4 1804 1808 B-gender
patients 5 13 1809 1817 I-gender
, 13 14 1817 1818 O
even 15 19 1819 1823 O
if 20 22 1824 1826 O
surgically 23 33 1827 1837 B-treatment
sterilized 34 44 1838 1848 I-treatment
( 45 46 1849 1850 O
ie 46 48 1850 1852 O
, 48 49 1852 1853 O
status 50 56 1854 1860 O
post 57 61 1861 1865 B-treatment
- 61 62 1865 1866 I-treatment
vasectomy 62 71 1866 1875 I-treatment
) 71 72 1875 1876 O

Non 0 3 1877 1880 B-cancer
- 3 4 1880 1881 I-cancer
small 4 9 1881 1886 I-cancer
cell 10 14 1887 1891 I-cancer
lung 15 19 1892 1896 I-cancer
cancer 20 26 1897 1903 I-cancer

Ongoing 0 7 1904 1911 O
or 8 10 1912 1914 O
active 11 17 1915 1921 B-chronic_disease
systemic 18 26 1922 1930 I-chronic_disease
infection 27 36 1931 1940 I-chronic_disease
, 36 37 1940 1941 O
active 38 44 1942 1948 B-chronic_disease
hepatitis 45 54 1949 1958 I-chronic_disease
B 55 56 1959 1960 I-chronic_disease
or 57 59 1961 1963 I-chronic_disease
C 60 61 1964 1965 I-chronic_disease
virus 62 67 1966 1971 I-chronic_disease
infection 68 77 1972 1981 I-chronic_disease
, 77 78 1981 1982 O
or 79 81 1983 1985 O
known 82 87 1986 1991 O
human 88 93 1992 1997 B-chronic_disease
immunodeficiency 94 110 1998 2014 I-chronic_disease
virus 111 116 2015 2020 I-chronic_disease
( 117 118 2021 2022 I-chronic_disease
HIV 118 121 2022 2025 I-chronic_disease
) 121 122 2025 2026 I-chronic_disease
positive 123 131 2027 2035 O

Pancreatic 0 10 2036 2046 B-cancer
ductal 11 17 2047 2053 I-cancer
adenocarcinoma 18 32 2054 2068 I-cancer
patient 33 40 2069 2076 O
with 41 45 2077 2081 O
KRAS 46 50 2082 2086 O
point 51 56 2087 2092 O
mutation 57 65 2093 2101 O
at 66 68 2102 2104 O
codon 69 74 2105 2110 O
G12 75 78 2111 2114 O
or 79 81 2115 2117 O
G13 82 85 2118 2121 O

Patient 0 7 2122 2129 O
has 8 11 2130 2133 O
greater 12 19 2134 2141 O
than 20 24 2142 2146 O
or 25 27 2147 2149 O
equal 28 33 2150 2155 O
than 34 38 2156 2160 O
Grade 39 44 2161 2166 B-lower_bound
2 45 46 2167 2168 I-lower_bound
peripheral 47 57 2169 2179 B-chronic_disease
neuropathy 58 68 2180 2190 I-chronic_disease
, 68 69 2190 2191 O
or 70 72 2192 2194 O
Grade 73 78 2195 2200 O
1 79 80 2201 2202 O
with 81 85 2203 2207 O
pain 86 90 2208 2212 O
on 91 93 2213 2215 O
clinical 94 102 2216 2224 O
examination 103 114 2225 2236 O
during 115 121 2237 2243 O
the 122 125 2244 2247 O
screening 126 135 2248 2257 O
period 136 142 2258 2264 O

Patient 0 7 2265 2272 O
who 8 11 2273 2276 O
were 12 16 2277 2281 O
receiving 17 26 2282 2291 O
prior 27 32 2292 2297 B-treatment
therapy 33 40 2298 2305 I-treatment
will 41 45 2306 2310 O
require 46 53 2311 2318 O
wash 54 58 2319 2323 O
out 59 62 2324 2327 O
period 63 69 2328 2334 O
of 70 72 2335 2337 O
either 73 79 2338 2344 O
more 80 84 2345 2349 O
than 85 89 2350 2354 O
2 90 91 2355 2356 B-lower_bound
weeks 92 97 2357 2362 I-lower_bound
or 98 100 2363 2365 O
more 101 105 2366 2370 O
than 106 110 2371 2375 O
5 111 112 2376 2377 B-lower_bound
half 113 117 2378 2382 O
- 117 118 2382 2383 O
lives 118 123 2383 2388 O
whichever 124 133 2389 2398 O
shorter 134 141 2399 2406 O

Patients 0 8 2407 2415 O
that 9 13 2416 2420 O
have 14 18 2421 2425 O
previously 19 29 2426 2436 O
been 30 34 2437 2441 O
treated 35 42 2442 2449 O
with 43 47 2450 2454 O
ixazomib 48 56 2455 2463 B-treatment
, 56 57 2463 2464 O
or 58 60 2465 2467 O
participated 61 73 2468 2480 O
in 74 76 2481 2483 O
a 77 78 2484 2485 O
study 79 84 2486 2491 O
with 85 89 2492 2496 O
ixazomib 90 98 2497 2505 O
whether 99 106 2506 2513 O
treated 107 114 2514 2521 O
with 115 119 2522 2526 O
ixazomib 120 128 2527 2535 O
or 129 131 2536 2538 O
not 132 135 2539 2542 O

Patients 0 8 2543 2551 O
with 9 13 2552 2556 O
Eastern 14 21 2557 2564 B-clinical_variable
Cooperative 22 33 2565 2576 I-clinical_variable
Oncology 34 42 2577 2585 I-clinical_variable
Group 43 48 2586 2591 I-clinical_variable
Performance 49 60 2592 2603 I-clinical_variable
Status 61 67 2604 2610 I-clinical_variable
( 68 69 2611 2612 I-clinical_variable
ECOG 69 73 2612 2616 I-clinical_variable
PS 74 76 2617 2619 I-clinical_variable
) 76 77 2619 2620 I-clinical_variable
of 78 80 2621 2623 O
0 81 82 2624 2625 B-lower_bound
or 83 85 2626 2628 O
1 86 87 2629 2630 B-upper_bound

Radiotherapy 0 12 2631 2643 B-treatment
completed 13 22 2644 2653 O
within 23 29 2654 2660 O
2 30 31 2661 2662 B-upper_bound
weeks 32 37 2663 2668 I-upper_bound
prior 38 43 2669 2674 I-upper_bound
to 44 46 2675 2677 O
treatment 47 56 2678 2687 B-treatment
initiation 57 67 2688 2698 O

Since 0 5 2699 2704 O
KRAS 6 10 2705 2709 O
mutation 11 19 2710 2718 O
is 20 22 2719 2721 O
present 23 30 2722 2729 O
in 31 33 2730 2732 O
more 34 38 2733 2737 O
than 39 43 2738 2742 O
90 44 46 2743 2745 B-lower_bound
% 46 47 2745 2746 I-lower_bound
of 48 50 2747 2749 O
pancreatic 51 61 2750 2760 B-cancer
cancer 62 68 2761 2767 I-cancer
with 69 73 2768 2772 O
98 74 76 2773 2775 B-upper_bound
% 76 77 2775 2776 I-upper_bound
of 78 80 2777 2779 O
the 81 84 2780 2783 O
mutation 85 93 2784 2792 O
found 94 99 2793 2798 O
at 100 102 2799 2801 O
codon 103 108 2802 2807 O
12 109 111 2808 2810 O
, 111 112 2810 2811 O
we 113 115 2812 2814 O
expect 116 122 2815 2821 O
majority 123 131 2822 2830 O
of 132 134 2831 2833 O
patients 135 143 2834 2842 O
with 144 148 2843 2847 O
pancreatic 149 159 2848 2858 B-cancer
ductal 160 166 2859 2865 I-cancer
adenocarcinoma 167 181 2866 2880 I-cancer

We 0 2 2881 2883 O
will 3 7 2884 2888 O
enroll 8 14 2889 2895 O
non 15 18 2896 2899 B-cancer
- 18 19 2899 2900 I-cancer
small 19 24 2900 2905 I-cancer
cell 25 29 2906 2910 I-cancer
lung 30 34 2911 2915 I-cancer
cancer 35 41 2916 2922 I-cancer
patients 42 50 2923 2931 O
with 51 55 2932 2936 O
documented 56 66 2937 2947 O
EGFR 67 71 2948 2952 O
mutation 72 80 2953 2961 O
who 81 84 2962 2965 O
failed 85 91 2966 2972 O
treatment 92 101 2973 2982 O
with 102 106 2983 2987 O
anti 107 111 2988 2992 B-treatment
- 111 112 2992 2993 I-treatment
EGFR 112 116 2993 2997 I-treatment
therapy 117 124 2998 3005 I-treatment
( 125 126 3006 3007 O
e.g. 126 130 3007 3011 O
erlotinib 131 140 3012 3021 B-treatment
or 141 143 3022 3024 O
afatinib 144 152 3025 3033 B-treatment
) 152 153 3033 3034 O
and 154 157 3035 3038 O
tested 158 164 3039 3045 O
negative 165 173 3046 3054 O
for 174 177 3055 3058 O
EGFR 178 182 3059 3063 O
T790 183 187 3064 3068 O
M 187 188 3068 3069 O
mutation 189 197 3070 3078 O

agree 0 5 3079 3084 B-contraception_consent
to 6 8 3085 3087 I-contraception_consent
practice 9 17 3088 3096 I-contraception_consent
2 18 19 3097 3098 I-contraception_consent
effective 20 29 3099 3108 I-contraception_consent
methods 30 37 3109 3116 I-contraception_consent
of 38 40 3117 3119 I-contraception_consent
contraception 41 54 3120 3133 I-contraception_consent

first 0 5 3134 3139 O
5 6 7 3140 3141 O
patients 8 16 3142 3150 O
from 17 21 3151 3155 O
both 22 26 3156 3160 O
non 27 30 3161 3164 B-cancer
- 30 31 3164 3165 I-cancer
small 31 36 3165 3170 I-cancer
cell 37 41 3171 3175 I-cancer
lung 42 46 3176 3180 I-cancer
cancer 47 53 3181 3187 I-cancer
and 54 57 3188 3191 O
pancreatic 58 68 3192 3202 B-cancer
ductal 69 75 3203 3209 I-cancer
adenocarcinoma 76 90 3210 3224 I-cancer
patients 91 99 3225 3233 O
will 100 104 3234 3238 O
need 105 109 3239 3243 O
to 110 112 3244 3246 O
agree 113 118 3247 3252 O
to 119 121 3253 3255 O
mandatory 122 131 3256 3265 B-treatment
pre- 132 136 3266 3270 I-treatment
and 137 140 3271 3274 I-treatment
post 141 145 3275 3279 I-treatment
- 145 146 3279 3280 I-treatment
treatment 146 155 3280 3289 I-treatment
tumor 156 161 3290 3295 I-treatment
biopsies 162 170 3296 3304 I-treatment

from 0 4 3305 3309 O
the 5 8 3310 3313 O
time 9 13 3314 3318 O
of 14 16 3319 3321 O
signing 17 24 3322 3329 O
the 25 28 3330 3333 O
informed 29 37 3334 3342 O
consent 38 45 3343 3350 O
form 46 50 3351 3355 O
through 51 58 3356 3363 O
90 59 61 3364 3366 B-upper_bound
days 62 66 3367 3371 I-upper_bound
after 67 72 3372 3377 O
the 73 76 3378 3381 O
last 77 81 3382 3386 O
dose 82 86 3387 3391 O
of 87 89 3392 3394 O
study 90 95 3395 3400 O
drug 96 100 3401 3405 O

psychiatric 0 11 3406 3417 B-chronic_disease
disorder 12 20 3418 3426 I-chronic_disease

